TI
NKGN

Telemetry Investments’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Telemetry Investments’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$593K Hold
59,561
– – 0.94% 27
2022
Q3 		$581K Hold
59,561
– – 0.74% 42
2022
Q2 		$578K Hold
59,561
– – 0.68% 42
2022
Q1 		$578K Buy
59,561
+5,900
+11% +$57.2K 0.91% 41
2021
Q4 		$518K Sell
53,661
-400
-0.7% -$3.89K 0.67% 50
2021
Q3 		$524K Buy
+54,061
New +$527K 0.71% 46

Other funds holding NKGN

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Telemetry Investments's NKGN Position: Q4 2022 in Review

Telemetry Investments held its NKGen Biotech, Inc. Common Stock (NKGN) position steady in Q4 2022 at 59,561 shares worth $593K. The position accounts for 0.94% of the portfolio, ranked #27.

Telemetry Investments first reported a position in NKGN in Q3 2021 and has held it in 6 quarters since. 60 funds tracked by Wall St. Rank hold NKGN as of Q4 2022.

  • Telemetry Investments held 59,561 shares of NKGen Biotech, Inc. Common Stock worth $593K as of Q4 2022.
  • Telemetry Investments left its NKGen Biotech, Inc. Common Stock share count unchanged in Q4 2022.
  • NKGen Biotech, Inc. Common Stock made up 0.94% of Telemetry Investments's portfolio in Q4 2022, its #27 holding.
  • Telemetry Investments first reported a position in NKGen Biotech, Inc. Common Stock in Q3 2021 and has held it in 6 quarters since.
  • 60 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.